Federico Cazzaniga

Federico Cazzaniga

Presentazione:

BIOLOGIST
SC Neurologia 5 - Neuropatologia
(italian version)

 

I obtained Master degree in Molecular Biology at University of Milano-Bicocca and a Ph.D. degree in Clinical and Experimental medicine at University of Milan in 2018. I am currently attending the school of specialization in Clinical Pathology and Clinical Biochemistry at University of Pavia.  Since 2017 I am a researcher at the Neuropathology laboratory of the UOC Neurology 5 - Neuropathology at the Fondazione IRCCS Istituto Neurologico Carlo Besta.

 

Research activity 

My current research activity includes the study of the molecular events which lead to neurodegeneration and the development of innovative and sensitive tests based on PMCA and RT-QuIC analysis for an early and definitive diagnosis of different types of dementia, including Prion diseases, Parkinson’s disease (and other synucleinopathies), Alzheimer’s disease, Frontotemporal Dementia, Progressive Supranuclear Palsy and Corticobasal Degeneration, using body fluids (blood, urine and cerebrospinal fluid) and peripheral tissues (olfactory mucosa and skin biopsy).

 

Topics of interest

  • Neurodegenerative Disorders
  • Biomarkers
  • Amyloidosis

 

 

Contacts

+39 02.2394.2231

email: federico.cazzaniga@istituto-besta.it

Federico Cazzaniga

BIOLOGIST
SC Neurologia 5 - Neuropatologia
(italian version)

 

I obtained Master degree in Molecular Biology at University of Milano-Bicocca and a Ph.D. degree in Clinical and Experimental medicine at University of Milan in 2018. I am currently attending the school of specialization in Clinical Pathology and Clinical Biochemistry at University of Pavia.  Since 2017 I am a researcher at the Neuropathology laboratory of the UOC Neurology 5 - Neuropathology at the Fondazione IRCCS Istituto Neurologico Carlo Besta.

 

Research activity 

My current research activity includes the study of the molecular events which lead to neurodegeneration and the development of innovative and sensitive tests based on PMCA and RT-QuIC analysis for an early and definitive diagnosis of different types of dementia, including Prion diseases, Parkinson’s disease (and other synucleinopathies), Alzheimer’s disease, Frontotemporal Dementia, Progressive Supranuclear Palsy and Corticobasal Degeneration, using body fluids (blood, urine and cerebrospinal fluid) and peripheral tissues (olfactory mucosa and skin biopsy).

 

Topics of interest

  • Neurodegenerative Disorders
  • Biomarkers
  • Amyloidosis

 

 

Contacts

+39 02.2394.2231

email: federico.cazzaniga@istituto-besta.it

Responsabile della pubblicazione: Direzione Scientifica

Ultimo aggiornamento: 10/01/2023